Agios Says CHMP Adopts Positive Opinion For PYRUKYND To Treat Pyruvate Kinase Deficiency In Adults

RTTNews | 970 hari yang lalu
Agios Says CHMP Adopts Positive Opinion For PYRUKYND To Treat Pyruvate Kinase Deficiency In Adults

(RTTNews) - Agios Pharmaceuticals, Inc. (AGIO) announced Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion on September 15, 2022, recommending the granting of a marketing authorization for PYRUKYND (mitapivat) for the treatment of pyruvate kinase (PK) deficiency in adult patients.

PK deficiency is a rare, debilitating, lifelong hemolytic anemia. PYRUKYND is a first-in-class, oral PK activator that was recently approved by the U.S. Food and Drug Administration (FDA).

If approved by the European Commission (EC), PYRUKYND will be the first approved disease-modifying therapy for European patients with PK deficiency.

PYRUKYND was previously granted orphan drug designation by the EMA.

The positive CHMP opinion was based on results from two pivotal studies, ACTIVATE and ACTIVATE-T, conducted in not regularly transfused and regularly transfused adults with PK deficiency, respectively.

read more
U.S. Consumer Prices Rise 0.2% In April, Slightly Less Than Expected

U.S. Consumer Prices Rise 0.2% In April, Slightly Less Than Expected

Consumer prices in the U.S. rose by slightly less than expected in the month of April, according to a report released by the Labor Department on Tuesday. The Labor Department said its consumer price index inched up by 0.2 percent in April after edging down by 0.1 percent in March. Economists had expected consumer prices to rise by 0.3 percent.
RTTNews | 3j 25min yang lalu
Bayer Q1 Results Down, Sees Pharma Results At Top End Of View; Stock Gains

Bayer Q1 Results Down, Sees Pharma Results At Top End Of View; Stock Gains

Bayer AG on Tuesday confirmed its currency-adjusted 2025 targets after reporting lower earnings in its first quarter with slightly lower sales. The quarterly results reflected weak results in the Crop Science Division, despite growth in Pharmaceuticals and Consumer Health segments. Shares of the Pharmaceutical and life sciences major were gaining around 6 percent on the XETRA in Germany.
RTTNews | 4j 18min yang lalu
Bay Street May Open On Subdued Note; U.S. Inflation Data In Focus

Bay Street May Open On Subdued Note; U.S. Inflation Data In Focus

Futures indicate a somewhat subdued start for the Canadian market on Tuesday. However, U.S. consumer price inflation data is likely to make an impact on stocks as the inflation numbers from the world's largest economy could give some clues about the Federal Reserve's policy moves.
RTTNews | 4j 39min yang lalu
UK Labor Market Cools Down In Q1

UK Labor Market Cools Down In Q1

The UK unemployment rate edged up and wage growth softened in the first quarter ahead of the rise in payroll taxes, official data revealed on Tuesday. The unemployment rate rose to 4.5 percent in the three months to March, in line with expectations, from 4.4 percent in the three months to February, the Office for National Statistics reported.
RTTNews | 4j 41min yang lalu
FTSE 100 Modestly Higher In Cautious Trade

FTSE 100 Modestly Higher In Cautious Trade

U.K. stocks are up in positive territory a little past noon on Tuesday, although gains are just modest as investors make cautious moves, choosing to wait for more news on the economic as well as trade front.
RTTNews | 5j 39min yang lalu
CAC 40 Up Slightly In Lackluster Trade

CAC 40 Up Slightly In Lackluster Trade

French stocks are turning in a mixed performance on Tuesday, and the benchmark CAC 40 is moving along the flat line as investors are largely making cautious moves after previous session's solid upmove.
RTTNews | 6j 1min yang lalu
DAX Up Marginally In Cautious Trade; Bayer Rises Nearly 9%

DAX Up Marginally In Cautious Trade; Bayer Rises Nearly 9%

German stocks are moving in a tight range on Tuesday with investors largely making cautious moves, after a solid session on Monday thanks to news about U.S. and China striking a trade deal. Investors are digesting the data on German investor sentiment, and the latest batch of corporate earnings updates.
RTTNews | 6j 17min yang lalu